Reference:
1. Cerda C, Bruguera M, Pares A. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J Gastroenterol 2013; 19(32): 5381-4.
2. Simon RR, Marks V, Leeds AR, et al. A comprehensive of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals. Diabetes Medtab Res Rev 2011; 27: 14-27.
3. MICROMEDEX 2.0® [Database on the internet]: Truven health analytics; 2013. mobileMicromedex® , Glucosamine ; [cited 2013 Nov 14]. Available from: http://www.micromedexsolutions.com
Keywords:
-